Kalgene Inc. — Form D/A
Kalgene Inc. of MONTREAL, A8, a company, filed a Form D amendment with the SEC on 2021-09-28. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-28
- Form: D/A
- Accession: 0001867929-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.7M
- Amount sold: $3.7M
- Investors: 29
- Date of first sale: 2021-06-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-403855
Issuer
- Name: Kalgene Inc.
- CIK: 0001867929
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 6100 ROYALMOUNT AVENUE, MONTREAL, A8, H4P2R2
- Phone: (416) 697-9212
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Nickolay V Kukekov | Executive Officer | Melville, NY |
| Anthony J Giovinazzo | Director | Calgary, A0 |
| Benoit V Cyr | Director | Montreal, A8 |
| Michal V Prywata | Director | Montreal, A8 |
| Thillainathan V Yoganathan | Director | Montreal, A8 |
| Daniel Hetu | Director | Montreal, A8 |
| Thillainathan Yoganathan | Director | Montreal, A8 |
| Benoit Cyr | Director | Montreal, A8 |
| Jacki Jenuth | Director | Montreal, A8 |
| Jacki Jenuth | Executive Officer | Montreal, A8 |
| James Eric Callaway | Director | Montreal, A8 |
| James Eric Callaway | Executive Officer | Montreal, A8 |
Other filings by this issuer (2)
More